Cv Sciences Inc (OP: CVSI )
0.6250
USD
-0.0050
(-0.79%)
Official Closing Price
Updated: 3:59 PM EST, Jan 15, 2021
Add to My Watchlist
Stories about Cv Sciences Inc
Cannabis Stock Gainers And Losers From December 22, 2020
December 22, 2020
From Benzinga
These Alternative Pot Stocks To Watch May Be Strong Future Plays
August 27, 2020
Why Are These Two Pot Stocks To Watch So Popular?
August 13, 2020
Cannabis Stock Gainers And Losers From August 5, 2020
August 05, 2020
From Benzinga
Cannabis Stock Gainers And Losers From July 22, 2020
July 22, 2020
From Benzinga
Cannabis Stock Gainers And Losers From June 24, 2020
June 24, 2020
From Benzinga
From Benzinga
From Benzinga
CV Sciences: Q1 Earnings Insights
May 08, 2020
From Benzinga
The Daily Biotech Pulse: Ayala IPO, Pluristem Starts Phase 2 Trial Of COVID Treatment, European Nod For Takeda
May 08, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
March 24, 2020
From Benzinga
The Week In Cannabis: Marijuana Stocks Outperform The S&P During Coronavirus Pandemic
March 22, 2020
From Benzinga
The Week Ahead In Biotech: COVID-19 Updates, Tapering Earnings Flow, Eton's Seizure Drug Review
March 15, 2020
From Benzinga
From Benzinga
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
March 08, 2020
From Benzinga
Cannabis Stock Gainers And Losers From March 2, 2020
March 02, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Friday
February 28, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 27, 2020
From Benzinga
Dollar Volume In GBTC More Than Doubled In January, As Coronavirus Fears Spurred A Crypto Rally
February 24, 2020
From Benzinga
Has The CBD Market Hit A Major Point Of Saturation?
February 19, 2020
Tags
Stocks / Equities
From Blogs - TalkMarkets
A Dutch Brewing Company And Grocery Conglomerate Were 2 Of The Most Actively Traded Securities On OTC Markets In December
January 10, 2020
From Benzinga
Cannabis Securities Were Widely Traded On OTC Markets In November
December 17, 2019
From Benzinga
Analyst: No Near-Term Catalysts Ahead For Consumer CBD
December 10, 2019
From Benzinga
Stocks That Hit 52-Week Lows On Friday
December 06, 2019
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
December 03, 2019
From Benzinga
Here’s how investors should think about the FDA’s warning on CBD
November 26, 2019
From MarketWatch
Stocks That Hit 52-Week Lows On Wednesday
November 20, 2019
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
November 19, 2019
From Benzinga
These Were The Most Active Securities On OTC Markets In October
November 13, 2019
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.